Contact and support
Need help, have a question, or want to contact the ResearchHub team?
© 2026 ResearchHub. Built for responsible scholarly connection.
Privacy-aware community infrastructureResearch graph
References from A review of exosomes as nanomedicine for antimicrobial delivery and combating antimicrobial resistance. Local targets link to admitted publications; unresolved targets remain external evidence.
Hallmarks of exosomes
2022 · External reference
Exosomes: composition, biogenesis and function
10.1038/nri855 · 2002 · External reference
Exosomes released from macrophages infected with intracellular pathogens stimulate a proinflammatory response in vitro and in vivo
10.1182/blood-2007-03-079152 · 2007 · External reference
Recent advances in extracellular vesicles for therapeutic cargo delivery
10.1038/s12276-024-01201-6 · 2024 · External reference
Antibacterial drug discovery in the resistance era
10.1038/nature17042 · 2016 · External reference
Zingiber officinale-derived exosome-like nanoparticles as antimicrobial agents via lipid-mediated inhibition
10.1088/2632-959x/ad9299 · 2024 · External reference
Exosome-encapsulated antibiotic against intracellular infections of methicillin-resistant S. aureus
10.2147/ijn.s179380 · 2018 · External reference
Antibacterial effect of honey-derived exosomes containing antimicrobial peptides against oral streptococci
10.2147/ijn.s315040 · 2021 · External reference
The machinery of exosomes: biogenesis, release, and uptake
10.3390/ijms24021337 · 2023 · External reference
The biogenesis and secretion of exosomes and multivesicular bodies (MVBs): intercellular shuttles and implications in human diseases
10.1016/j.gendis.2022.03.021 · 2023 · External reference
Exosome biogenesis: machinery, regulation, and therapeutic implications in cancer
10.1186/s12943-022-01671-0 · 2022 · External reference
Exosomes: biogenesis, targeting, characterization and their potential as 'plug & play' vaccine platforms
10.1002/biot.202100646 · 2022 · External reference
Regulation of cargo selection in exosome biogenesis and its biomedical applications in cancer
10.1038/s12276-024-01209-y · 2024 · External reference
Exosomal therapy-a new frontier in regenerative medicine
10.21037/sci-2020-037 · 2021 · External reference
Isolation and characterization of exosomes from cell culture supernatants and biological fluids
10.1002/0471143030.cb0322s30 · 2006 · External reference
Mesenchymal stromal cell-derived tailored exosomes treat bacteria-associated diabetes foot ulcers: a customized approach from bench to bed
10.3389/fmicb.2021.712588 · 2021 · External reference
Regulation of cargo selection in exosome biogenesis and its biomedical applications in cancer
10.1038/s12276-024-01209-y · 2024 · External reference
Ceramide triggers budding of exosome vesicles into multivesicular endosomes
10.1126/science.1153124 · 2008 · External reference
Mesenchymal stem cell-derived exosomes: a promising biological tool in nanomedicine
2020 · External reference
Progress in exosome isolation techniques
10.7150/thno.18133 · 2017 · External reference
Proteomic comparison defines novel markers to characterize heterogeneous populations of extracellular vesicle subtypes
10.1073/pnas.1521230113 · 2016 · External reference
Unresolved reference
External reference
The Ikaros family of zinc-finger proteins
10.1016/j.apsb.2016.06.002 · 2016 · External reference
Exosomes: therapy delivery tools and biomarkers of diseases
10.1016/j.pharmthera.2017.02.020 · 2017 · External reference
The biology, function, and biomedical applications of exosomes
10.1126/science.aau6977 · 2020 · External reference
Host derived exosomes-pathogens interactions: potential functions of exosomes in pathogen infection
10.1016/j.biopha.2018.09.174 · 2018 · External reference
Regulation of immune responses by extracellular vesicles
10.1038/nri3622 · 2014 · External reference
Extracellular vesicles and infectious diseases: new complexity to an old story
10.1172/jci81132 · 2016 · External reference
Exosomes derived from M. Bovis BCG infected macrophages activate antigen-specific CD4+ and CD8+ T cells in vitro and in vivo
10.1371/journal.pone.0002461 · 2008 · External reference
Microvesicles and viral infection
10.1128/jvi.05853-11 · 2011 · External reference
Exosome biogenesis and biological function in response to viral infections
10.2174/1874357901812010134 · 2018 · External reference
Exosomes
10.1146/annurev-biochem-013118-111902 · 2019 · External reference
Development of extracellular vesicle therapeutics: challenges, considerations, and opportunities
10.3389/fcell.2021.734720 · 2021 · External reference
Biomimetic strategies of cell membrane vesicles driven by pathogen-host interactions: novel insights into antimicrobial immunotherapy and infection prevention
10.3389/fimmu.2025.1681889 · 2025 · External reference
Small extracellular vesicles as key players in cancer development caused by human oncogenic viruses
10.1186/s13027-022-00471-x · 2022 · External reference
State-of-the-art exosome loading and functionalization techniques for enhanced therapeutics: a review
10.1080/07388551.2020.1785385 · 2020 · External reference
Exosome isolation and characterization for advanced diagnostic and therapeutic applications
2025 · External reference
Biology, pathophysiological role, and clinical implications of exosomes: a critical appraisal
10.3390/cells8020099 · 2019 · External reference
Functionalized exosomes for targeted therapy in cancer and regenerative medicine: genetic, chemical, and physical modifications
10.1186/s12964-025-02268-y · 2025 · External reference
Microfluidic technology for the isolation and analysis of exosomes
2022 · External reference
Current strategies for exosome cargo loading and targeting delivery
10.3390/cells12101416 · 2023 · External reference
Drug loading techniques for exosome-based drug delivery systems
10.31083/ph.2021.0128 · 2021 · External reference
Exosomes─nature’s lipid nanoparticles, a rising star in drug delivery and diagnostics
10.1021/acsnano.2c08774 · 2022 · External reference
Remote loading of preencapsulated drugs into stealth liposomes
10.1073/pnas.1324135111 · 2014 · External reference
Mechanistic studies on pH-permeability relationships: impact of the membrane polar headgroup region on pKa
10.1016/j.ijpharm.2025.125383 · 2025 · External reference
Cell‐derived vesicles for antibiotic delivery—understanding the challenges of a biogenic carrier system
10.1002/smll.202207479 · 2023 · External reference
Hydrogel‐loaded exosomes: a promising therapeutic strategy for musculoskeletal disorders
10.1155/2023/1105664 · 2023 · External reference
Paclitaxel incorporated exosomes derived from glioblastoma cells: comparative study of two loading techniques
10.1007/s40199-019-00280-5 · 2019 · External reference
Exosomes as emerging drug delivery and diagnostic modality for breast cancer: recent advances in isolation and application
10.3390/cancers14061435 · 2022 · External reference
Exploring the synergistic behavior of paclitaxel and vorinostat upon co-loading in albumin nanoparticles for breast cancer management
10.1007/s13346-023-01415-7 · 2024 · External reference
A new approach for loading anticancer drugs into mesenchymal stem cell-derived exosome mimetics for cancer therapy
10.3389/fphar.2018.01116 · 2018 · External reference
Facile and scalable fabrication of exosome-mimicking nanovesicles through PEGylated lipid detergent-aided cell extrusion
10.1039/d2nr04272j · 2022 · External reference
CAR-exosomes derived from immune cells: an emerging nanoscale vanguard in overcoming tumor immunotherapy hurdles
2025 · External reference
Exosomes engineering and their roles as therapy delivery tools, therapeutic targets, and biomarkers
10.3390/ijms22179543 · 2021 · External reference
Exosomes as drug delivery systems: endogenous nanovehicles for treatment of systemic lupus erythematosus
10.3390/pharmaceutics13010003 · 2020 · External reference
Nano-formulation approaches to enhance transdermal drug delivery- an updated review of nanovesicular carrier “transethosomes”
10.2174/0122117385306281240427073651 · 2025 · External reference
Exosome-liposome hybrid nanoparticle codelivery of TP and miR497 conspicuously overcomes chemoresistant ovarian cancer
10.1186/s12951-022-01264-5 · 2022 · External reference
Integrated therapy platform of exosomal system: hybrid inorganic/organic nanoparticles with exosomes for cancer treatment
10.1039/d1nh00637a · 2022 · External reference
NRP-1 targeted and cargo-loaded exosomes facilitate simultaneous imaging and therapy of glioma in vitro and in vivo
10.1016/j.biomaterials.2018.06.029 · 2018 · External reference
The application of exosomes from different sources loaded with natural small-molecule compounds in disease
10.2147/ijn.s542641 · 2025 · External reference
Exosomes as drug delivery vehicles for Parkinson’s disease therapy
10.1016/j.jconrel.2015.03.033 · 2015 · External reference
Exosome-based drug delivery: translation from bench to clinic
10.3390/pharmaceutics15082042 · 2023 · External reference
Active loading into extracellular vesicles significantly improves the cellular uptake and photodynamic effect of porphyrins
10.1016/j.jconrel.2014.11.029 · 2015 · External reference
Hybrid exosomes, exosome-like nanovesicles and engineered exosomes for therapeutic applications
10.1016/j.jconrel.2022.12.027 · 2023 · External reference
Copper(I)-catalyzed alkyne-azide cycloaddition (CuAAC) “click” reaction: a powerful tool for functionalizing polyhydroxylated platforms
10.1021/acsomega.2c06269 · 2023 · External reference
Engineering of M2 macrophages-derived exosomes via click chemistry for spinal cord injury repair
10.1002/adhm.202203391 · 2023 · External reference
Eradicating intracellular MRSA via targeted delivery of lysostaphin and vancomycin with mannose-modified exosomes
10.1016/j.jconrel.2020.11.045 · 2021 · External reference
Exosomes as novel delivery systems for application in traditional chinese medicine
10.3390/molecules27227789 · 2022 · External reference
Engineering macrophage-derived exosomes for targeted paclitaxel delivery to pulmonary metastases: in vitro and in vivo evaluations
10.1016/j.nano.2017.09.011 · 2018 · External reference
Chemically modified extracellular vesicles and applications in radiolabeling and drug delivery
2022 · External reference
Molecular farming for sustainable production of clinical-grade antimicrobial peptides
10.1111/pbi.14344 · 2024 · External reference
The immune response of the small interfering RNA pathway in the defense against bee viruses
10.1016/j.cois.2014.09.014 · 2014 · External reference
The role of antimicrobial peptides in overcoming antibiotic resistance
10.1016/j.microb.2025.100337 · 2025 · External reference
The role of antimicrobial peptides in innate immunity1
10.1093/icb/43.2.300 · 2003 · External reference
Antimicrobial peptides as therapeutics: confronting delivery challenges to optimize efficacy
10.1016/j.microb.2024.100051 · 2024 · External reference
Exosome-based drug delivery: translation from bench to clinic
10.3390/pharmaceutics15082042 · 2023 · External reference
Encapsulation and assessment of therapeutic cargo in engineered exosomes: a systematic review
10.1186/s12951-023-02259-6 · 2024 · External reference
Cell-derived nanoplatforms for the delivery of cancer therapeutics
10.3390/ijms22010014 · 2020 · External reference
Monoclonal antibody-based therapies for microbial diseases
10.1016/j.vaccine.2009.09.105 · 2009 · External reference
Examining alternative approaches to antibiotic utilisation: a critical evaluation of phage therapy and antimicrobial peptides combination as potential alternatives
10.1016/j.microb.2025.100254 · 2025 · External reference
Standardization approaches for extracellular vesicle loading with oligonucleotides and biologics
10.1002/smll.202301763 · 2023 · External reference
Quantitative and stoichiometric analysis of the microRNA content of exosomes
10.1073/pnas.1408301111 · 2014 · External reference
Cardiac progenitor cell‑derived exosomes promote H9C2 cell growth via Akt/mTOR activation
2018 · External reference
Therapeutic potential of mesenchymal cell-derived miRNA-150-5p-expressing exosomes in rheumatoid arthritis mediated by the modulation of MMP14 and VEGF
10.4049/jimmunol.1800304 · 2018 · External reference
Systemically injected exosomes targeted to EGFR deliver antitumor microRNA to breast cancer cells
10.1038/mt.2012.180 · 2013 · External reference
Delivery of exogenous miR-124 to glioblastoma multiform cells by wharton’s jelly mesenchymal stem cells decreases cell proliferation and migration, and confers chemosensitivity
10.1007/s12015-017-9788-3 · 2018 · External reference
Enhancement of gemcitabine sensitivity in pancreatic adenocarcinoma by novel exosome-mediated delivery of the Survivin-T34A mutant
10.3402/jev.v3.23244 · 2014 · External reference
Exosomes from marrow stromal cells expressing miR-146b inhibit glioma growth
10.1016/j.canlet.2013.02.019 · 2013 · External reference
Anti-HER2 scFv-directed extracellular vesicle-mediated mRNA-based gene delivery inhibits growth of HER2-positive human breast tumor xenografts by prodrug activation
10.1158/1535-7163.mct-17-0827 · 2018 · External reference
Transfection reagent artefact likely accounts for some reports of extracellular vesicle function
10.1002/jev2.12253 · 2022 · External reference
Mesenchymal stem cells and their derived exosomes promote malignant phenotype of polyploid non-small-cell lung cancer cells through AMPK signaling pathway
2022 · External reference
Transfer of the cystic fibrosis transmembrane conductance regulator to human cystic fibrosis cells mediated by extracellular vesicles
10.1089/hum.2015.144 · 2016 · External reference
Sumoylated hnRNPA2B1 controls the sorting of miRNAs into exosomes through binding to specific motifs
10.1038/ncomms3980 · 2013 · External reference
In vitro and in vivo RNA inhibition by CD9-HuR functionalized exosomes encapsulated with miRNA or CRISPR/dCas9
10.1021/acs.nanolett.8b02689 · 2019 · External reference
Protein targeting to exosomes/microvesicles by plasma membrane anchors*
10.1074/jbc.m110.208660 · 2011 · External reference
Extracellular vesicle in vivo biodistribution is determined by cell source, route of administration and targeting
10.3402/jev.v4.26316 · 2015 · External reference
Quantification of protein cargo loading into engineered extracellular vesicles at single-vesicle and single-molecule resolution
10.1002/jev2.12130 · 2021 · External reference
Tumour-bound RNA-laden exosomes
10.1038/s41551-017-0119-4 · 2017 · External reference
Bovine milk-derived exosomes for drug delivery
10.1016/j.canlet.2015.10.020 · 2016 · External reference
Exosomes as drug delivery vehicles for Parkinson’s disease therapy
10.1016/j.jconrel.2015.03.033 · 2015 · External reference
Exosome-mediated delivery of functionally active miRNA-155 inhibitor to macrophages
10.1016/j.nano.2014.03.014 · 2014 · External reference
Functional exosome-mimic for delivery of siRNA to cancer: in vitro and in vivo evaluation
10.1016/j.jconrel.2016.10.008 · 2016 · External reference
Loading of extracellular vesicles with chemically stabilized hydrophobic siRNAs for the treatment of disease in the central nervous system
2017 · External reference
Exosome-mediated delivery of hydrophobically modified siRNA for huntingtin mRNA silencing
10.1038/mt.2016.126 · 2016 · External reference
Sorting it out: regulation of exosome loading
10.1016/j.semcancer.2014.04.009 · 2014 · External reference
Targeting soluble proteins to exosomes using a ubiquitin tag
10.1002/bit.25884 · 2016 · External reference
Treatment of brain inflammatory diseases by delivering exosome encapsulated anti-inflammatory drugs from the nasal region to the brain
10.1038/mt.2011.164 · 2011 · External reference
Engineered exosomes as vehicles for biologically active proteins
10.1016/j.ymthe.2017.03.030 · 2017 · External reference
Abstract 2167: efficient and rapid cellular delivery of bioactive proteins using EXPLOR: exosomes engineered for protein loading via optically reversible protein-protein interaction
10.1158/1538-7445.am2016-2167 · 2016 · External reference
Exosome engineering for efficient intracellular delivery of soluble proteins using optically reversible protein–protein interaction module
10.1038/ncomms12277 · 2016 · External reference
Light-inducible exosome-based vehicle for endogenous RNA loading and delivery to leukemia cells
10.1002/adfm.201807189 · 2019 · External reference
Engineering hybrid exosomes by membrane fusion with liposomes
10.1038/srep21933 · 2016 · External reference
Cellular engineering with membrane fusogenic liposomes to produce functionalized extracellular vesicles
10.1021/acsami.6b01315 · 2016 · External reference
Aptamers as therapeutics
10.1038/nrd3141 · 2010 · External reference
Immunomodulatory properties of MSC-derived exosomes armed with high affinity aptamer toward mylein as a platform for reducing multiple sclerosis clinical score
10.1016/j.jconrel.2019.02.032 · 2019 · External reference
Vesicular stomatitis virus G glycoprotein pseudotyped retroviral vectors: concentration to very high titer and efficient gene transfer into mammalian and nonmammalian cells
10.1073/pnas.90.17.8033 · 1993 · External reference
Unresolved reference
External reference
Enhanced induction of dendritic cell maturation and HLA-A*0201-restricted CEA-specific CD8(+) CTL response by exosomes derived from IL-18 gene-modified CEA-positive tumor cells
10.1007/s00109-006-0102-0 · 2006 · External reference
More efficient induction of HLA-A*0201-restricted and carcinoembryonic antigen (CEA)–specific CTL response by immunization with exosomes prepared from heat-stressed CEA-positive tumor cells
10.1158/1078-0432.ccr-05-0810 · 2005 · External reference
A strategy of antigen incorporation into exosomes: comparing cross-presentation levels of antigens delivered by engineered exosomes and by lentiviral virus-like particles
10.1016/j.vaccine.2012.10.010 · 2012 · External reference
Use of engineered exosomes expressing HLA and costimulatory molecules to generate antigen-specific CD8+ T cells for adoptive cell therapy
10.1097/cji.0000000000000151 · 2017 · External reference
A doxorubicin delivery platform using engineered natural membrane vesicle exosomes for targeted tumor therapy
10.1016/j.biomaterials.2013.11.083 · 2014 · External reference
Peptide–drug conjugates as next-generation therapeutics: exploring the potential and clinical progress
10.3390/bioengineering12050481 · 2025 · External reference
Enhanced loading of functional miRNA Cargo via pH Gradient modification of extracellular vesicles
10.1016/j.ymthe.2019.12.007 · 2020 · External reference
Localized conformational interrogation of antibody and antibody-drug conjugates by site-specific carboxyl group footprinting
10.1080/19420862.2016.1268306 · 2017 · External reference
Freeze thaw and lyophilization induced alteration in mAb therapeutics: trastuzumab as a case study
10.1016/j.jpba.2021.114122 · 2021 · External reference
Effect of microencapsulation shear stress on the structural integrity and biological activity of a model monoclonal antibody, trastuzumab
10.3390/pharmaceutics3030510 · 2011 · External reference
Effect of thermal and shear stressors on the physical properties, structural integrity and biological activity of the anti-TNF-alpha monoclonal antibody, Infliximab
10.2174/1389201017666160519111815 · 2016 · External reference
Analysis of streptokinase by validated liquid chromatography methods and correlation with an in vitro bioassay
10.1002/jssc.201600880 · 2017 · External reference
Stability of protein pharmaceuticals: an update
10.1007/s11095-009-0045-6 · 2010 · External reference
Oxidation and deamidation of monoclonal antibody products: potential impact on stability, biological activity, and efficacy
10.1016/j.xphs.2021.11.024 · 2022 · External reference
Differentiating the effects of oxidative stress tests on biopharmaceuticals
10.1007/s11095-019-2627-2 · 2019 · External reference
Biological stability of peptides/proteins therapeutic agents
10.1007/s10989-023-10549-8 · 2023 · External reference
Unresolved reference
External reference
EV-TRACK: transparent reporting and centralizing knowledge in extracellular vesicle research
10.1038/nmeth.4185 · 2017 · External reference
Quality and safety considerations for therapeutic products based on extracellular vesicles
10.1007/s11095-024-03757-4 · 2024 · External reference
Human blood exosomes: isolation and characterization methods, variability, and the need for standardized protocols-a review
10.3390/biomedicines13122970 · 2025 · External reference
Macrophages in cardiac repair: environmental cues and therapeutic strategies
10.1038/s12276-019-0269-4 · 2019 · External reference
Exosomes as therapeutic drug carriers and delivery vehicles across biological membranes: current perspectives and future challenges
10.1016/j.apsb.2016.02.001 · 2016 · External reference
Plasma exosomes can deliver exogenous short interfering RNA to monocytes and lymphocytes
10.1093/nar/gks463 · 2012 · External reference
Delivery of siRNA to the mouse brain by systemic injection of targeted exosomes
10.1038/nbt.1807 · 2011 · External reference
Exosomes: mobile platforms for targeted and synergistic signaling across cell boundaries
10.1007/s00018-016-2413-9 · 2017 · External reference
Extracellular vesicles for drug delivery
10.1016/j.addr.2016.02.006 · 2016 · External reference
Extracellular vesicles as a platform for membrane-associated therapeutic protein delivery
10.1080/20013078.2018.1440131 · 2018 · External reference
Application of exosomes in tumor immunity: recent progresses
10.3389/fcell.2024.1372847 · 2024 · External reference
Exosomes mediate stromal mobilization of autocrine Wnt-PCP signaling in breast cancer cell migration
10.1016/j.cell.2012.11.024 · 2012 · External reference
Immune targeting of tetraspanins involved in cell invasion and metastasis
10.3389/fimmu.2018.01277 · 2018 · External reference
Tetraspanins in extracellular vesicle formation and function
10.3389/fimmu.2014.00442 · 2014 · External reference
The tetraspanins CD151 and Tspan8 are essential exosome components for the crosstalk between cancer initiating cells and their surrounding
10.18632/oncotarget.2958 · 2015 · External reference
More than markers of extracellular vesicles in reproduction
10.3390/ijms21207568 · 2020 · External reference
Lack of involvement of CD63 and CD9 tetraspanins in the extracellular vesicle content delivery process
10.1038/s42003-023-04911-1 · 2023 · External reference
Exosomes as a next-generation drug delivery system: an update on drug loading approaches, characterization, and clinical application challenges
10.1016/j.actbio.2020.06.036 · 2020 · External reference
Engineering blood exosomes for tumor-targeting efficient gene/chemo combination therapy
10.7150/thno.45028 · 2020 · External reference
Exosome nanovesicles: a potential carrier for therapeutic delivery
10.1016/j.nantod.2023.101771 · 2023 · External reference
New advances in exosome-based targeted drug delivery systems
10.1016/j.critrevonc.2022.103628 · 2022 · External reference
‘Marker-of-self’ functionalization of nanoscale particles through a top-down cellular membrane coating approach
10.1039/c3nr00015j · 2013 · External reference
Exosomes facilitate therapeutic targeting of oncogenic KRAS in pancreatic cancer
10.1038/nature22341 · 2017 · External reference
Extracellular vesicle-based therapeutics: natural versus engineered targeting and trafficking
10.1038/s12276-019-0223-5 · 2019 · External reference
Aptamer-based biosensors for biomedical diagnostics
10.1039/c4an00132j · 2014 · External reference
Exosome/antimicrobial peptide laden hydrogel wound dressings promote scarless wound healing through miR-21-5p-mediated multiple functions
10.1016/j.biomaterials.2024.122558 · 2024 · External reference
Human umbilical cord mesenchymal stem cell-derived exosomes promote murine skin wound healing by neutrophil and macrophage modulations revealed by single-cell RNA sequencing
2023 · External reference
Applications of cancer cell-specific aptamers in targeted delivery of anticancer therapeutic agents
10.3390/molecules23040830 · 2018 · External reference
Aptamer-functionalized exosomes: elucidating the cellular uptake mechanism and the potential for cancer-targeted chemotherapy
10.1021/acs.analchem.8b05204 · 2019 · External reference
Rational identification of a colorectal cancer targeting peptide through phage display
10.1038/s41598-019-40562-1 · 2019 · External reference
Targeting strategies for tissue-specific drug delivery
10.1016/j.cell.2020.02.001 · 2020 · External reference
Targeted exosome-based nanoplatform for new-generation therapeutic strategies
10.1088/1748-605x/ad3310 · 2024 · External reference
Reduction of choroidal neovascularization via cleavable VEGF antibodies conjugated to exosomes derived from regulatory T cells
10.1038/s41551-021-00764-3 · 2021 · External reference
Tumor-homing pH-sensitive extracellular vesicles for targeting heterogeneous tumors
10.3390/pharmaceutics12040372 · 2020 · External reference
Functionalized layer-by-layer assembled film with directional 5-fluorouracil release to target colon cancer
10.1016/j.msec.2020.111118 · 2020 · External reference
Large-scale generation of functional mRNA-encapsulating exosomes via cellular nanoporation
10.1038/s41551-019-0485-1 · 2020 · External reference
Tumour exosome integrins determine organotropic metastasis
10.1038/nature15756 · 2015 · External reference
Pharmacokinetics of exosomes-an important factor for elucidating the biological roles of exosomes and for the development of exosome-based therapeutics
10.1016/j.xphs.2017.02.030 · 2017 · External reference
An overview of the antimicrobial resistance mechanisms of bacteria
10.3934/microbiol.2018.3.482 · 2018 · External reference
Antimicrobial resistance, mechanisms and its clinical significance
10.1016/j.disamonth.2020.100971 · 2020 · External reference
General principles of antibiotic resistance in bacteria
10.1016/j.ddtec.2014.02.001 · 2014 · External reference
Antimicrobials as promoters of genetic variation
10.1016/j.mib.2012.07.007 · 2012 · External reference
Bacterial resistance to antibiotics: modified target sites
10.1016/j.addr.2005.04.003 · 2005 · External reference
Methicillin-resistant S. aureus (MRSA): molecular aspects of antimicrobial resistance and virulence
2009 · External reference
Mechanisms of quinolone action and microbial response
10.1093/jac/dkg207 · 2003 · External reference
Resistance to macrolide, lincosamide, streptogramin, ketolide, and oxazolidinone antibiotics
10.1385/mb:28:1:47 · 2004 · External reference
Effect of rpoB mutations conferring rifampin resistance on fitness of Mycobacterium tuberculosis
10.1128/aac.48.4.1289-1294.2004 · 2004 · External reference
Metallo-beta-lactamases of P. aeruginosa–a novel mechanism resistance to beta-lactam antibiotics
2008 · External reference
Antimicrobial resistance in bacteria: mechanisms, evolution, and persistence
10.1007/s00239-019-09914-3 · 2020 · External reference
Molecular basis of bacterial resistance to chloramphenicol and florfenicol
10.1016/j.femsre.2004.04.001 · 2004 · External reference
Multidrug efflux pumps in Gram-negative bacteria and their role in antibiotic resistance
10.2217/fmb.14.66 · 2014 · External reference
Adaptive and mutational resistance: role of porins and efflux pumps in drug resistance
10.1128/cmr.00043-12 · 2012 · External reference
Diffusion of carbapenems through the outer membrane of enterobacteriaceae and correlation of their activities with their periplasmic concentrations
10.1089/mdr.1996.2.273 · 1996 · External reference
Efflux-mediated antimicrobial resistance
10.1093/jac/dki171 · 2005 · External reference
Efflux pumps as antimicrobial resistance mechanisms
10.1080/07853890701195262 · 2007 · External reference
Clinically relevant chromosomally encoded multidrug resistance efflux pumps in bacteria
10.1128/cmr.19.2.382-402.2006 · 2006 · External reference
Routes and mechanisms of extracellular vesicle uptake
10.3402/jev.v3.24641 · 2014 · External reference
Enhanced antibacterial activity of bovine milk exosome-based drug formulation against bacterial pathogens
10.1016/j.foodchem.2024.139034 · 2024 · External reference
The immunomodulation potential of exosomes in tumor microenvironment
10.1155/2021/3710372 · 2021 · External reference
Exosomes: new molecular targets of diseases
10.1038/aps.2017.162 · 2018 · External reference
The use of exosome carrier to augmentation of Helicobacter pylori infection treatment
10.21037/sci-2020-028 · 2020 · External reference
Stem cell therapy for the treatment of parasitic infections: is it far away?
10.1007/s00436-013-3689-4 · 2014 · External reference
Antibiotics–past, present, and future
10.1016/j.mcna.2006.06.007 · 2006 · External reference
Mesenchymal stem cell-derived extracellular vesicles decrease lung injury in mice
10.4049/jimmunol.1801534 · 2019 · External reference
Emerging role of exosomes in tuberculosis: from immunity regulations to vaccine and immunotherapy
2021 · External reference
Current landscape of exosomes in tuberculosis development, diagnosis, and treatment applications
2024 · External reference
An injectable hydrogel bioimplant loaded with engineered exosomes and triple anti-tuberculosis drugs with potential for treating bone and joint tuberculosis
10.2147/ijn.s480288 · 2025 · External reference
Functional significance of exosomes applied in sepsis: a novel approach to therapy
10.1016/j.bbadis.2016.10.024 · 2017 · External reference
Case report: administration of amniotic fluid-derived nanoparticles in three severely ill COVID-19 patients
2021 · External reference
Extracellular vesicles: a promising therapy against SARS-CoV-2 infection
10.1016/j.ymthe.2023.03.033 · 2023 · External reference
A pilot study for treatment of severe COVID-19 pneumonia by aerosolized formulation of convalescent human immune plasma exosomes (ChipEXO™)
10.3389/fimmu.2022.963309 · 2022 · External reference
Clinical applications of stem cell-derived exosomes
10.1038/s41392-023-01704-0 · 2024 · External reference
The origins of acquired immune deficiency syndrome viruses: where and when?
10.1098/rstb.2001.0863 · 2001 · External reference
Exosome-mediated stable epigenetic repression of HIV-1
10.1038/s41467-021-25839-2 · 2021 · External reference
Engineered exosome for drug delivery: recent development and clinical applications
10.2147/ijn.s444582 · 2023 · External reference
Application of exosomes-derived mesenchymal stem cells in treatment of fungal diseases: from basic to clinical sciences
10.3389/ffunb.2021.736093 · 2021 · External reference
Macrophage-derived CD36 + exosome subpopulations as novel biomarkers of Candida albicans infection
10.1038/s41598-024-60032-7 · 2024 · External reference
Emerging role of exosomes in diagnosis and treatment of infectious and inflammatory bowel diseases
10.3390/cells9051111 · 2020 · External reference
What are biomarkers?
10.1097/coh.0b013e32833ed177 · 2010 · External reference
Potential use of exosomes as diagnostic biomarkers and in targeted drug delivery: progress in clinical and preclinical applications
10.1021/acsbiomaterials.1c00217 · 2021 · External reference
Detection of Mycobacterium tuberculosis peptides in the exosomes of patients with active and latent M. tuberculosis infection using MRM-MS
10.1371/journal.pone.0103811 · 2014 · External reference
RNA profiling analysis of the serum exosomes derived from patients with active and latent Mycobacterium tuberculosis infection
10.3389/fmicb.2017.01051 · 2017 · External reference
Small RNA profiles of serum exosomes derived from individuals with latent and active tuberculosis
10.3389/fmicb.2019.01174 · 2019 · External reference
Diagnostic and therapeutic applications of exosomes in cancer with a special focus on head and neck squamous cell carcinoma (HNSCC)
10.3390/ijms21124344 · 2020 · External reference
Cancer statistics, 2022
2022 · External reference
Early detection of cancer
10.1126/science.aay9040 · 2022 · External reference
The potential of exosomes in regenerative medicine and in the diagnosis and therapies of neurodegenerative diseases and cancer
2025 · External reference
Exosomes: a review of biologic function, diagnostic and targeted therapy applications, and clinical trials
10.1186/s12929-024-01055-0 · 2024 · External reference
Exosomes in cancer: diagnostic and therapeutic applications
2024 · External reference
Construction of exosome SORL1 detection platform based on 3D porous microfluidic chip and its application in early diagnosis of colorectal cancer
10.1002/smll.202207381 · 2023 · External reference
A novel urine exosomal lncRNA assay to improve the detection of prostate cancer at initial biopsy: a retrospective multicenter diagnostic feasibility study
10.3390/cancers13164075 · 2021 · External reference
Single test-based diagnosis of multiple cancer types using exosome-SERS-AI for early stage cancers
10.1038/s41467-023-37403-1 · 2023 · External reference
Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers
10.1038/ncb1800 · 2008 · External reference
Dietary zinc alters the microbiota and decreases resistance to Clostridium difficile infection
10.1038/nm.4174 · 2016 · External reference
Theranostic signature of tumor-derived exosomes in cancer
10.1007/s12032-023-02176-6 · 2023 · External reference
Scale-up of mammalian cell culture using a new multilayered flask
2011 · External reference
Advanced cell-based products generated via automated and manual manufacturing platforms under the quality by design principle: are they equivalent or different?
10.1016/j.heliyon.2023.e15946 · 2023 · External reference
Transcriptomic profiling of plasma extracellular vesicles enables reliable annotation of the cancer-specific transcriptome and molecular subtype
10.1158/0008-5472.can-23-4070 · 2024 · External reference
Production of extracellular vesicles using a CELLine adherent bioreactor flask
2022 · External reference
Investigating the consistency of extracellular vesicle production from breast cancer subtypes using CELLine adherent bioreactors
10.1002/jex2.60 · 2022 · External reference
Increased exosome production from tumour cell cultures using the integra CELLine culture system
10.1016/j.jim.2008.03.001 · 2008 · External reference
Production of mesenchymal stem cells through stem cell reprogramming
10.3390/ijms20081922 · 2019 · External reference
Scalable, cGMP-compatible purification of extracellular vesicles carrying bioactive human heterodimeric IL-15/lactadherin complexes
10.1080/20013078.2018.1442088 · 2018 · External reference
Large-scale preparation of extracellular vesicles enriched with specific microRNA
10.1089/ten.tec.2018.0249 · 2018 · External reference
Scalable production of human mesenchymal stromal cell-derived extracellular vesicles under serum-/xeno-free conditions in a microcarrier-based bioreactor culture system
2020 · External reference
Extracellular vesicles generated using bioreactors and their therapeutic effect on the acute kidney injury model
10.1002/adhm.202101606 · 2022 · External reference
Upscaling human mesenchymal stromal cell production in a novel vertical-wheel bioreactor enhances extracellular vesicle secretion and cargo profile
2023 · External reference
Extracellular vesicle biogenesis of three-dimensional human pluripotent stem cells in a novel Vertical-Wheel bioreactor
10.1002/jex2.133 · 2024 · External reference
Profiling biomanufactured extracellular vesicles of human forebrain spheroids in a vertical-wheel bioreactor
10.1002/jex2.70002 · 2024 · External reference
Non-clinical safety evaluation of exosomes derived from human umbilical cord mesenchymal stem cells in cynomolgus monkeys
10.2147/ijn.s454438 · 2024 · External reference
Exosome-mediated mRNA delivery in vivo is safe and can be used to induce SARS-CoV-2 immunity
10.1016/j.jbc.2021.101266 · 2021 · External reference
10.21203/rs.3.rs-626854/v1
10.21203/rs.3.rs-626854/v1 · External reference
Vaccination of metastatic melanoma patients with autologous dendritic cell (DC) derived-exosomes: results of thefirst phase I clinical trial
10.1186/1479-5876-3-10 · 2005 · External reference
CAR exosomes derived from effector CAR-T cells have potent antitumour effects and low toxicity
10.1038/s41467-019-12321-3 · 2019 · External reference
Clinical safety and efficacy of allogenic human adipose mesenchymal stromal cells-derived exosomes in patients with mild to moderate Alzheimer’s disease: a phase I/II clinical trial
10.1136/gpsych-2023-101143 · 2023 · External reference
Safety, efficacy and bio-distribution analysis of exosomes derived from human umbilical cord mesenchymal stem cells for effective treatment of bronchopulmonary dysplasia by intranasal administration in mice model
10.2147/ijn.s501843 · 2025 · External reference
Safety and potential effects of intrathecal injection of allogeneic human umbilical cord mesenchymal stem cell-derived exosomes in complete subacute spinal cord injury: a first-in-human, single-arm, open-label, phase I clinical trial
10.1186/s13287-024-03868-0 · 2024 · External reference
Toxicological evaluation of exosomes derived from human adipose tissue-derived mesenchymal stem/stromal cells
10.1016/j.yrtph.2020.104686 · 2020 · External reference
Safety and biodistribution of exosomes derived from human induced pluripotent stem cells
10.3389/fbioe.2022.949724 · 2022 · External reference
Inhalable CAR-T cell-derived exosomes as paclitaxel carriers for treating lung cancer
10.1186/s12967-023-04206-3 · 2023 · External reference
Guidelines for clinical translation and commercialization of extracellular vesicles and exosomes based therapeutics
10.1016/j.vesic.2023.100029 · 2023 · External reference
Updating MISEV: evolving the minimal requirements for studies of extracellular vesicles
10.1002/jev2.12182 · 2021 · External reference
Minimum information for studies of extracellular vesicles (MISEV) as toolbox for rigorous, reproducible and homogeneous studies on extracellular vesicles
10.1016/j.tiv.2025.106049 · 2025 · External reference
Standardized reporting of research on exosomes to ensure rigor and reproducibility
10.1089/wound.2024.0093 · 2024 · External reference
10.1016/b978-0-443-23891-8.00014-7
10.1016/b978-0-443-23891-8.00014-7 · External reference
10.1002/jev2.12451
10.1002/jev2.12451 · External reference
10.1080/20013078.2019.1648167
10.1080/20013078.2019.1648167 · External reference
10.1038/s12276-019-0223-5
10.1038/s12276-019-0223-5 · External reference
Considerations for the bioprocessing, manufacture and translation of extracellular vesicles for therapeutic and diagnostic applications
10.18609/cgti.2017.066 · 2017 · External reference
10.1002/jev2.12033
10.1002/jev2.12033 · External reference
Guidelines for clinical translation and commercialization of extracellular vesicles and exosomes based therapeutics
10.1016/j.vesic.2023.100029 · 2023 · External reference
Exosome-based mucosal therapeutic and diagnostic system: towards clinical translation
2025 · External reference
